The Airway Management Products Market is projected to grow from USD 1.72 billion in 2022 to USD 2.38 billion by 2028, with a CAGR of 5.5%. North America held over 35% of the market in 2022, driven by a rising elderly population, supportive reimbursement policies, and healthcare investments. The Asia-Pacific region is also set for strong growth, propelled by increasing awareness of respiratory diseases and healthcare infrastructure expansion.